Nomination adds significant expertise to support pharma partnerships and an impressive track record in value creation CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, February 1, 2022 (GLOBE …
News
CENTOGENE Announces USD 62 Million Aggregate Equity and Debt Financings to Support Growth Plan
Enables refocusing on core business of delivering valuable, data-driven insights to patients, and pharmaceutical companies globally EUR 15 million private placement from leading growth investors and …
CENTOGENE Announces Nomination of Kim Stratton as Chief Executive Officer
Dr. Andrin Oswald resigns as CEO due to prolonged medical leave; Kim Stratton elected as successor CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, February 1, 2022 (GLOBE NEWSWIRE – Centogene …
TVM Capital Life Science promotes Dr. Sascha Berger and Dr. Alain Thibault to General Partner
Munich, Germany / Montreal, Canada - 12 January 2022 – TVM Life Science (“TVM”), a leading International Life Sciences Venture Capital firm, today announces the formal promotion of Dr. Sascha Berger …
Syndivia and TVM Capital Life Science Announce Creation of Auricula Biosciences to Develop Innovative Therapy for Patients with K-Ras mutant malignancies
Luxembourg, January 13th, 2022 – TVM Life Science Innovation II SCSp announced the Fund's investment establishing Auricula Biosciences, Inc., a company based in Wilmington, Delaware, USA. Auricula …
Acer Therapeutics Reports Q3 2021 Financial Results and Provides Corporate Update
NEWTON, MA – Nov. 19, 2021 – Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and …